Lymphoid leukemia
MONDO:0005402A malignant lymphocytic neoplasm of B-cell or T-cell lineage involving primarily the bone marrow and the peripheral blood. This category includes precursor or acute lymphoblastic leukemias and chronic leukemias.
Also known as: leukemia, LYMPHOCYTIC, malignant, lymphocytic leukemia, lymphogenous leukaemia, lymphogenous leukemia, lymphoid leukaemia (disease), lymphoid leukemia, lymphoid leukemia (disease), subacute lymphoid leukaemia
3189 clinical trials for this condition and its sub-types, 24 tagged with Lymphoid leukemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Lymphoid leukemia
-
Acute lymphoblastic leukemia 508 trials · 1,319 incl. sub-types
12 sub-types
- B-cell chronic lymphocytic leukemia 509 trials · 538 incl. sub-types Sub-types →
- B-cell acute lymphoblastic leukemia 245 trials · 259 incl. sub-types Sub-types →
- Childhood acute lymphoblastic leukemia 96 trials · 136 incl. sub-types Sub-types →
- Precursor B-cell acute lymphoblastic leukemia 68 trials · 113 incl. sub-types Sub-types →
- T-cell acute lymphoblastic leukemia 75 trials · 104 incl. sub-types Sub-types →
- Acute biphenotypic leukemia 88 trials · 91 incl. sub-types Sub-types →
- Adult acute lymphoblastic leukemia 43 trials · 54 incl. sub-types Sub-types →
- Prolymphocytic leukemia 20 trials · 38 incl. sub-types Sub-types →
- Plasma cell leukemia 32 trials
- Lymphoblastic leukemia, acute, with lymphomatous features 7 trials
- Precursor T-cell acute lymphoblastic leukemia 4 trials
- Null-cell leukemia 0 trials
-
T-cell leukemia 9 trials · 137 incl. sub-types
3 sub-types
- T-cell acute lymphoblastic leukemia 75 trials · 104 incl. sub-types Sub-types →
- Adult T-cell leukemia/lymphoma 31 trials
- T-cell adult acute lymphocytic leukemia 3 trials
Most studied deeper sub-types
-
Experimental antibody GNR-084 tested against Hard-to-Treat leukemia
Disease control Stopped earlyResearchers are testing an experimental antibody called GNR-084 in adults with B-cell acute lymphoblastic leukemia that has come back or stopped responding to treatment. The trial enrolls 14 people aged 18 to 45 who have already received at least two prior therapies. Participants…
Phase 1/2 • Sponsor: AO GENERIUM • Aim: Disease control
Last updated Sep 21, 2026 15:00 UTC
-
New drug combo shows promise for Tough-to-Treat leukemia
Disease control Stopped earlyThis study tested a two-drug combination (ibrutinib and venetoclax) in 30 adults with chronic lymphocytic leukemia (CLL) that had returned or stopped responding to prior treatments. The goal was to see if starting with ibrutinib alone, then adding venetoclax, could safely clear t…
Phase 2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC